Themis Medicare Limited has informed the Exchange about General Updates
THEMISMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Themis Medicare has informed exchanges about updates regarding its preferential allotment of convertible warrants. The Board had approved this issuance in February 2026, and the company submitted applications to both BSE and NSE for in-principle approval. Following queries from the stock exchanges, the company has now obtained a Valuation Report from an Independent Registered Valuer and an updated Compliance Certificate from a Practicing Company Secretary. Both documents have been hosted on the company's website as part of regulatory compliance. This disclosure is made under SEBI's Regulation 30 of the LODR Regulations, 2015.
The company is progressing with its plan to raise capital through preferential allotment of convertible warrants. Existing shareholders should note that conversion of warrants will result in equity dilution. The involvement of independent valuation and compliance certificates suggests proper regulatory process is being followed.